Literature DB >> 1940585

Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.

V Dubernard1, C Legrand.   

Abstract

To characterize the interaction between thrombospondin and human platelets, thrombospondin was purified from the supernatant of thrombin-activated human platelets, labeled with iodine 125, and allowed to interact with the washed platelets. With concentrations of 10 to 50 micrograms/ml, only minute amounts of 125I-labeled thrombospondin bound to resting platelets or to platelets activated by adenosine diphosphate. In contrast, when platelets were stimulated with thrombin, binding increased fivefold to sixfold in a time-dependent and 125I-labeled thrombospondin concentration-dependent manner. Binding of 125I-labeled thrombospondin to thrombin-activated platelets required the presence of divalent cations, proceeded concomitantly with platelet release, and at a concentration of 1 nmol/L thrombin, reached a maximum of 2200 +/- 260 molecules of 125I-labeled thrombospondin bound per platelet. After its binding to platelets, 125I-labeled thrombospondin was not internalized, because up to 85% of the 125I-labeled thrombospondin was dissociated from the cell surface by adding ethylenediaminetetraacetic acid. Using various experimental approaches, including studies with severe type I thrombasthenic platelets, we further demonstrated that the interaction of 125I-labeled thrombospondin with thrombin-stimulated platelets occurred as a fibrinogen- and fibrin-independent process, and that the glycoprotein IIb-IIIa complex did not function as a physiologic plasma membrane receptor for 125I-labeled thrombospondin. Last, about 60% of the 125I-labeled thrombospondin molecules bound to the platelet surface were found to be associated with the platelet cytoskeleton recovered from platelets solubilized with Triton X-100. On Western blot analysis, this cytoskeletal fraction lacked detectable glycoprotein IV, the putative platelet receptor for thrombospondin. These results suggest that on the surface of thrombin-activated platelets, a fraction of 125I-labeled thrombospondin does not associate with glycoprotein IV but instead with other plasma membrane components that have yet to be identified.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940585

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  5 in total

1.  Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.

Authors:  Arnaud Bonnefoy; Kim Daenens; Hendrik B Feys; Rita De Vos; Petra Vandervoort; Jos Vermylen; Jack Lawler; Marc F Hoylaerts
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

2.  Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.

Authors:  J Koopman; F Haverkate; J Grimbergen; S T Lord; M W Mosesson; J P DiOrio; K S Siebenlist; C Legrand; J Soria; C Soria
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

3.  Role of thrombospondin in the adhesion of human endothelial cells in primary culture.

Authors:  V Morandi; F Fauvel-Lafeve; C Legrand; Y J Legrand
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

4.  Association of thrombospondin-1 with the actin cytoskeleton of human thrombin-activated platelets through an alphaIIbbeta3- or CD36-independent mechanism.

Authors:  Anne Saumet; Nando de Jesus; Chantal Legrand; Véronique Dubernard
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

5.  The postmortem activation status of platelets.

Authors:  H Thomsen; B Krisch
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.